Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

HydraMed vs Wisp

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.9

HydraMed

Best for patients wanting all-in pricing with a single intake fee
★★★★4

Starting at $179/mo

CompoundedSemaglutideTirzepatideFree shipping
Visit HydraMed
7.0

Wisp

Best for buyers who want a board-certified telehealth platform offering both branded injectables AND a sublingual alternative — with full disclosure that the sublingual form is not human-tested
★★★3.5

Starting at $225/mo

Brand WegovyBrand ZepboundBrand SaxendaCompounded Sublingual Semaglutide
Visit Wisp

Side-by-Side Comparison

FeatureHydraMedWisp
Overall Score7.9/107.0/10
Starting Price$179/mo$225/mo
Editorial Rating4 ★ /53.5 ★ /5
Features6 features6 features
States Available110
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

HydraMed

Pros

  • All-inclusive pricing with no add-ons
  • Free shipping
  • US FDA-registered compounding pharmacy
  • Quick intake process

Cons

  • Wide peptide menu beyond GLP-1s — patients should stay focused on FDA-approved indications
  • Trust score moderate pending more independent verification

Wisp

Pros

  • Wider GLP-1 menu than the prior stub suggested — both branded injectables (Wegovy, Zepbound, Saxenda) AND the compounded sublingual option
  • LegitScript certified, board-certified providers (Dr. Shannon Chatham DO, Andrea Sleeth WHNP-BC publicly named)
  • Wisp's product page uses appropriately cautious language around sublingual: 'lab tests using human-derived tissues suggest it may begin working' and 'effectiveness in patients may vary' — disclosure is more rigorous than most compounded GLP-1 marketing

Cons

  • EFFECTIVENESS CAVEAT: sublingual compounded semaglutide has not been tested in humans — Wisp's own product page explicitly states this. Injectables (Wegovy, Zepbound, Saxenda) on the same platform have FDA safety/efficacy data; sublingual does not.
  • Pharmacy partners not publicly named
  • States served list not publicly enumerated

Our Verdict

Winner: HydraMedScore: 7.9/10

HydraMed edges out Wisp with a higher overall score of 7.9/10 and is particularly strong for patients wanting all-in pricing with a single intake fee. Wisp remains a solid alternative, especially if you're looking for buyers who want a board-certified telehealth platform offering both branded injectables AND a sublingual alternative — with full disclosure that the sublingual form is not human-tested.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.